NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Husnu Efendi
Kocaeli University - Kocaeli / Türkiye
Others
AD Scientific Index ID: 210778
Kocaeli Üniversitesi
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Husnu Efendi's MOST POPULAR ARTICLES
1-)
Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosisSL Hauser, A Bar-Or, G Comi, G Giovannoni, HP Hartung, B Hemmer, ...New England Journal of Medicine 376 (3), 221-234, 201716282017
2-)
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 studyL Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ...The Lancet 391 (10127), 1263-1273, 20189172018
3-)
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind …JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ...The Lancet Neurology 16 (12), 976-986, 20175552017
4-)
Long‐term safety and efficacy of eculizumab in generalized myasthenia gravisS Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ...Muscle & nerve 60 (1), 14-24, 20192182019
5-)
Long-term safety and efficacy of teriflunomide: nine-year follow-up of the randomized TEMSO studyP O\'Connor, G Comi, MS Freedman, AE Miller, L Kappos, JP Bouchard, ...Neurology 86 (10), 920-930, 20161602016
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept